Lessons learned on the critical role of collaboration for effective genomic surveillance of SARS-CoV-2 variants
29 Jun 2021
Watch this presentation by Prof. Richard Michelmore, Director of the Genome Center at UC Davis, and Dr. Tania Nolan, Head of Assay Design and Development LGC, Biosearch Technologies, titled: Lessons learned on the critical role of collaboration for effective genomic surveillance of SARS-CoV-2 variants. This talk was presented at the SelectScience® Virtual Clinical Science Summit 2021.
About the company
LGC Diagnostics & Genomics - Biosearch Technologies Oligo Synthesis
LGC Diagnostics & Genomics
At LGC Diagnostics & Genomics, we drive scientific progress by making our trusted life science solutions both simpler and more innovative.
Partnering with our customers to provide a portfolio of cutting-edge life science tools that diagnose, treat and feed our growing population, delivering on our core mission of Science for a Safer World.
Biosearch Technologies Oligo Synthesis
Tailored oligo synthesis & components that deliver integrated solutions from feasibility through early development to commercialisation.
Advance molecular innovation with Biosearch Technologies’ high‑quality oligonucleotide synthesis and nucleic acid chemistry solutions. From early feasibility through clinical development and commercialisation, Biosearch Technologies delivers reliable, scalable oligo components and chemistry expertise that support assay performance, reproducibility and manufacturing confidence.
A flexible, end‑to‑end partner across the nucleic acid continuum, enabling customers to engage at any stage of development and scale seamlessly as programmes progress.